Adjunctive Brexpiprazole: A Review in Major Depressive Disorder Kate McKeage Adis Drug Evaluation 05 February 2016 Pages: 91 - 99
Novel Thrombolytics for Acute Ischemic Stroke: Challenges and Opportunities Nicola LogalloChristopher E. KvistadLars Thomassen Current Opinion 21 January 2016 Pages: 101 - 108
Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date Mary R. LeeMatthew C. H. RohnLorenzo Leggio Leading Article 01 March 2016 Pages: 109 - 123
Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia Thomas W. WeickertKatherine M. AllenCynthia S. Weickert Leading Article Open access 05 February 2016 Pages: 125 - 133
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis Samuel F. HunterJames D. BowenAnthony T. Reder Review Article Open access 29 December 2015 Pages: 135 - 147
Worldwide Differences in Regulations of Clozapine Use Jimmi NielsenCorina YoungDavid Taylor Review Article 16 February 2016 Pages: 149 - 161
The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective Thor-Henrik BrodtkorbMelissa BellPhilippe Laramée Original Research Article 15 February 2016 Pages: 163 - 177